Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T16:12:29.866Z.
Calculation as of: 2026-10-06T16:12:29.866Z.
Quote observation: 2026-10-06T16:10:19.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 12822cf5764c24a0ef00c724f2a960962c8ab94682162e48d6be38065653aaef
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
Market Cap
$10.35B
EV/EBITDA Ratio
10.66x
TTM Avg
14.93x
3Y Avg
21.92x
5Y Avg
22.71x
Market Cap
$10.24B
EV/EBITDA Ratio
11.48x
TTM Avg
14.07x
3Y Avg
18.68x
5Y Avg
23.02x
Market Cap
$10.12B
EV/EBITDA Ratio
20.80x
TTM Avg
24.30x
3Y Avg
24.10x
5Y Avg
21.70x
Market Cap
$10.73B
EV/EBITDA Ratio
5.87x
TTM Avg
6.58x
3Y Avg
8.00x
5Y Avg
8.11x
Market Cap
$10.09B
EV/EBITDA Ratio
68.51x
TTM Avg
66.53x
3Y Avg
81.35x
5Y Avg
68.10x
Market Cap
$10.01B
EV/EBITDA Ratio
19.36x
TTM Avg
10.46x
3Y Avg
9.60x
5Y Avg
10.77x
Market Cap
$9.99B
EV/EBITDA Ratio
27.91x
TTM Avg
22.27x
3Y Avg
19.88x
5Y Avg
21.50x
Market Cap
$10.97B
EV/EBITDA Ratio
33.54x
TTM Avg
20.02x
3Y Avg
35.15x
5Y Avg
96.65x
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ImmunityBio, Inc. (IBRX) | $10.35B | N/A | N/A | N/A | N/A |
| Globus Medical, Inc. (GMED)vs › | $10.35B | 10.66x | 14.93x | 21.92x | 22.71x |
| Align Technology, Inc. (ALGN)vs › | $10.24B | 11.48x | 14.07x | 18.68x | 23.02x |
| The Ensign Group, Inc. (ENSG)vs › | $10.12B | 20.80x | 24.30x | 24.10x | 21.70x |
| Universal Health Services, Inc. (UHS)vs › | $10.73B | 5.87x | 6.58x | 8.00x | 8.11x |
| Repligen Corporation (RGEN)vs › | $10.09B | 68.51x | 66.53x | 81.35x | 68.10x |
| Molina Healthcare, Inc. (MOH)vs › | $10.01B | 19.36x | 10.46x | 9.60x | 10.77x |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.99B | 27.91x | 22.27x | 19.88x | 21.50x |
| BioMarin Pharmaceutical Inc. (BMRN)vs › | $10.97B | 33.54x | 20.02x | 35.15x | 96.65x |
| The Cooper Companies, Inc. (COO)vs › | $11.00B | 14.42x | 16.31x | 19.01x | 21.10x |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
